.Avidity Biosciences pleased investors with period 1/2 data in Duchenne muscle dystrophy (DMD) Frida...
.Actinogen Medical's cortisol blocker has missed the key endpoint of a period 2 research in depressi...
.Antibody-drug conjugates (ADCs) have gone to the center of several a billion-dollar biobuck licensi...
.Possession supervisor TPG, which has sustained biotechs like Sionna Therapeutics and Santa Clam Ana...
.Merck & Co.'s TIGIT plan has actually gone through an additional drawback. Months after shutteri...
.After a year determined by pipeline cuts, the shift of its CEO and discharges, Exscientia is going ...
.Cullinan Rehab was excited enough with Port BioMed's bispecific immune system activator that it han...
.Within this full week's incident of "The Top Line," our team are actually diving into Strong Biotec...
.The confetti is actually still soaring from Eli Lilly's event commemorating the approval of Alzheim...
.Accept to recently's Chutes & Ladders, our roundup of substantial leadership hirings, shootings ...